Chemistry:Rilmazolam

Short description: Chemical compound

Rilmazolam

Clinical data
Trade names	(none, active metabolite of Rilmazafone)
Legal status
Legal status	Generally Legal
Identifiers
IUPAC name 8-chloro-6-(2-chlorophenyl)-N,N-dimethyl-4H-[1,2,4]triazolo[1,5-a][1,4]benzodiazepine-2-carboxamide
CAS Number	50330-59-1 Y
PubChem CID	148494
UNII	242T8WV28A
CompTox Dashboard (EPA)	DTXSID50198345
Chemical and physical data
3D model (JSmol)	Interactive image
SMILES CN(C)C(=O)C1=NN2C(=N1)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4Cl
InChI InChI=InChI=1S/C19H15Cl2N5O/c1-25(2)19(27)18-23-16-10-22-17(12-5-3-4-6-14(12)21)13-9-11(20)7-8-15(13)26(16)24-18/h3-9H,10H2,1-2H3 Key:YMJXPUGNWIWFJI-UHFFFAOYSA-N

Rilmazolam, is a benzodiazepine derivative which acts as a sedative and hypnotic drug, and the active metabolite of the drug Rilmazafone. It has never been developed for medical uses, yet the aforementioned prodrug is an approved medication in Japan .

See also

• Flutazolam
• Etizolam
• Phenazepam
• Mexazolam
• Rilmazafone